Atorvastatin inhibits hyperglycemia-induced expression of osteopontin in the diabetic rat kidney via the p38 MAPK pathway

[1]  Hans Förstl,et al.  Diabetes , 2013, Der Diabetologe.

[2]  V. Pīrāgs,et al.  A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease , 2013, Diabetes & vascular disease research.

[3]  G. Kato,et al.  Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia , 2012, Haematologica.

[4]  T. Ahluwalia,et al.  Association of an Osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[5]  K. Dhatariya.  Perioperative management of adults with diabetes: why do we need guidance? , 2012, British journal of hospital medicine.

[6]  W. R. Taylor,et al.  Reactive Oxygen Species Regulate Osteopontin Expression in a Murine Model of Postischemic Neovascularization , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Higaki,et al.  Osteopontin Plays a Critical Role in Interstitial Fibrosis but Not Glomerular Sclerosis in Diabetic Nephropathy , 2012, Nephron Extra.

[8]  R. Bellomo,et al.  Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery , 2012, Nephrology.

[9]  L. Groop,et al.  Pleiotropic Effects of GIP on Islet Function Involve Osteopontin , 2011, Diabetes.

[10]  Y. Wang,et al.  Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin , 2011, Molecular Biology Reports.

[11]  H. Makino,et al.  Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice , 2011, Diabetes.

[12]  T. Haneji,et al.  High glucose levels increase osteopontin production and pathologic calcification in rat dental pulp tissues. , 2010, Journal of endodontics.

[13]  Hong Yu,et al.  Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling. , 2010, Biochemical and biophysical research communications.

[14]  W. Hsueh,et al.  Critical role for osteopontin in diabetic nephropathy. , 2010, Kidney international.

[15]  G. Chipitsyna,et al.  Expression and regulation of osteopontin in type 1 diabetes , 2009, Islets.

[16]  K. Suszták,et al.  The role of osteopontin in the development of albuminuria. , 2008, Journal of the American Society of Nephrology : JASN.

[17]  Danny Meetoo,et al.  An epidemiological overview of diabetes across the world. , 2007, British journal of nursing.

[18]  K. Kirkwood,et al.  p38 MAPK Signaling in Oral-related Diseases , 2007, Journal of dental research.

[19]  B. Shen,et al.  Novel strategies for inhibition of the p38 MAPK pathway. , 2007, Trends in pharmacological sciences.

[20]  I. G. Fantus,et al.  Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. , 2006, Kidney international.

[21]  A. R. Vancha,et al.  Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. , 2005, The Journal of endocrinology.

[22]  Takeo Kato,et al.  Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. , 2004, Endocrine journal.

[23]  D. Liang,et al.  Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. , 2004, Diabetes.

[24]  A. Junaid,et al.  Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3‐kinase‐mediated enhancement of expression by glucose in human proximal tubular epithelial cells , 2004, Histopathology.

[25]  Chul-woo Yang,et al.  Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. , 2003, Kidney international.

[26]  E. Wolski,et al.  Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  R. Bonow,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.

[28]  J. Mckenney,et al.  Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. , 2001, The American journal of cardiology.

[29]  D. Batlle,et al.  Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. , 2001, Diabetes.

[30]  D. Batlle,et al.  Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. , 2001, American journal of physiology. Renal physiology.

[31]  M. Cooper,et al.  Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. , 2000, Kidney international.

[32]  D. Batlle,et al.  Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. , 2000, Kidney international.

[33]  T. Shigematsu,et al.  Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Bitar,et al.  Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia. , 1997, Diabetes research and clinical practice.

[35]  S. Schwartz,et al.  Osteopontin Expression in Cardiovascular Diseases a , 1995, Annals of the New York Academy of Sciences.

[36]  Mahipal Singh,et al.  Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[37]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[38]  R. Atkins,et al.  J Am Soc Nephrol 14: 338–351, 2003 Blockade of p38 � MAPK Ameliorates Acute Inflammatory Renal Injury in Rat Anti-GBM Glomerulonephritis , 2022 .